Research, data analysis, and commentary on abortion, fertility trends, and pro-natal policies.
“…misoprostol, can be safely and effectively used on its own.” That’s what MSI Reproductive Choices is telling the public about a medical abortion treatment known to fail once in every five cases. This statement follows a similar one by Dr Grossman, a leading abortion researcher and advocate in the U.S., “What do people need to... Continue Reading →
Medical Abortion (MA), aka the abortion pill, doesn’t always work; it is well-established that MA has an expected and commonly occurring treatment failure rate of about 5%. Meaning that as many as 1-in-20 pregnant women using abortion pills will subsequently need additional medical treatment for complications arising from an incomplete abortion. Medical abortion treatment failure... Continue Reading →
In 2021/22, the twelve months ending March 2022, BPAS performed 93,136 abortions, an increase of 18% over the total in 2017/18, a period in which the total number of abortions in England and Wales increased by 11%. BPAS continues to expand its share of the UK abortion market, providing about 43% of the total in... Continue Reading →
New York Times review Research shows that the abortion pill fails in 5% of cases – that’s the findings from a New York Times review of 101 studies covering 124,000 first trimester abortions performed in 26 countries over the last 30 years. Non-negligible risk of failure. It is well-known that medical abortion will sometimes fail,... Continue Reading →
It's not just about ‘safety’ – the abortion pill (mifepristone and misoprostol) is medically safe for the woman; serious complications from medical abortion including hospitalisation, blood transfusion, major surgery, or death are rare. Arguing for changes to the legal and regulatory control of medical abortion solely based on safety is a very weak argument. Now... Continue Reading →
Abortions at home data in tab T2 of this file at https://www.gov.uk/government/statistics/abortion-statistics-for-england-and-wales-2021
"In the product literature the frequency of side-effects is generally described as above." This is from the British National Formulary at NICE.
Data obtained from five NHS Ambulance Trusts in England, show that emergency ambulance responses for complications arising after a medical abortion are three times higher for women using pills-by-post at home, compared to those who have their medical abortion in a clinic. Using our rights under the Freedom of Information Act, we asked each of... Continue Reading →
BPAS has reported that its abortion services are “under considerable pressure” and that the number of calls it has been receiving increased by about a third in the six months March to September this year. During the same period our volunteers were making mystery client calls to BPAS and MSI Reproductive Choices, and we found... Continue Reading →
Did you know that the Government and Abortion Providers routinely under report the rate of complications caused by abortion pills? Our freedom of information investigation reveals that less than 1-in-5 complications are being reported. DHSC Under Report. The official DHSC statistics for 2020 show a 1.1% complication rate for all medical abortions and only 0.3%... Continue Reading →
Medical abortion doesn't always work; it is well established that MA has an expected treatment failure rate of about 6%. Which means that as many as 1-in-17 pregnant women using abortion pills will subsequently need hospital treatment for complications arising from an incomplete abortion. Ranbaxy (UK) Limited is the manufacturer of Medabon, the mifepristone/misoprostol combination... Continue Reading →
Data published by the Office of National Statistics, show clearly that the increasing gap between conceptions and births is due to the increasing number of abortions. The ONS notes: "Prior to 1969, the first full year for which abortions data were available, the number of conceptions was equivalent to the number of births." Source: Office... Continue Reading →
We consider the possibility that the mere experience of pain, without the capacity for self reflection, is morally significant. We believe that fetal pain does not have to be equivalent to a mature adult human experience to matter morally, and so fetal pain might be considered as part of a humane approach to abortion. Derbyshire... Continue Reading →
A total of 4.1% of all medical abortions done at less than 12 weeks gestational age were incomplete and required surgical care in the form of a vacuum curettage procedure. Carlsson, I., Breding, K. & Larsson, PG. Complications related to induced abortion: a combined retrospective and longitudinal follow-up study. BMC Women's Health 18, 158 (2018). https://doi.org/10.1186/s12905-018-0645-6
Gynuity Health Projects, a pro-abortion activist organisation, recently published results from its own study into the safety and efficacy of telemedicine abortion. Two key findings are: Six percent of women using abortion pills at home, subsequently needed hospital treatment because of complications related to the abortion, a rate of 1-in-17. Four percent of women using... Continue Reading →
In its SmPC (summaries of product characteristics), Ranbaxy states that there is a non-negligible risk of medical abortion treatment failure, as follows: The non-negligible risk of failure, which occurs in 4.5 to 7.8% of the cases, makes the follow-up visit mandatory in order to check that abortion is complete. The patient should be informed that... Continue Reading →
Emergency Calls Double. Surge in 999 calls over at home abortions after NHS controversially started sending powerful pills by post. There is a worrying development, emergency call-outs related to the abortion pills have *doubled* in some regions.
One day this month, we will reach these numbers: 🏘️200,000 women taking the abortion pills at home, since Government approval on 30 March 2020; 🏥10,000 of these women being treated in hospital for complications arising from taking the abortion pills. #EndImmediately
In 2020, Marie Stopes global provision of abortion fell by 40%. They provided 2,800,000 abortions compared to 4.6m in 2019. The original 'target/goal' for 2020 was 5m abortions. The CEO's remuneration has fallen by 43% from 2018, down to £244,000 from a high of £434,000.
Marie Stopes Australia (MSA) says that more than 5% of the medical abortions it provides, fail to complete. Meaning that 1-in-20 women will have fragments of the baby and/or placenta remaining in their womb after taking both sets of the tablets, mifepristone and misoprostol. These women will need to seek further treatment to prevent ongoing... Continue Reading →
